Introduction of local Anaesthetic
Classification based on the linker moiety
Classification based on pharmacological action and route of administration
Mechanism of action of local Anaesthetic
Introduction of local Anaesthetic
Classification based on the linker moiety
Classification based on pharmacological action and route of administration
Mechanism of action of local Anaesthetic
Pharmacology of Cholinergic Drugs. It contains a detailed elaboration of Cholinergic Agents, Cholinomimmetics, Cholinergic Antagonists, Synthesis of Ach, Receptors, Classification, Mechanism of Action, Pharmacokinetics and Dynamics, Dosage and Adverse effects
All chemicals other than food that affect living processes are called drugs.
This presentation will give a brief introduction of drugs and their action.
The systemic vasculitides are characterized by immune inflammation affecting blood vessels, which can lead to organ and tissue damage.
One study showed that 8% of Wegener's granulomatosis (WG) patients had some degree of AATD (Alpha-1 antitrypsin deficiency). It's perhaps wise for all WG patients to be tested for AATD, especially if they're having bronchiectasis or similar conditions affecting breathing. Some rheumatologists order a lab test for AATD whenever a WG patient is diagnosed.
This presentation, reviews this topic and hypothesize the role of replacement therapy in patients affected by both conditions.
Pharmacology of Cholinergic Drugs. It contains a detailed elaboration of Cholinergic Agents, Cholinomimmetics, Cholinergic Antagonists, Synthesis of Ach, Receptors, Classification, Mechanism of Action, Pharmacokinetics and Dynamics, Dosage and Adverse effects
All chemicals other than food that affect living processes are called drugs.
This presentation will give a brief introduction of drugs and their action.
The systemic vasculitides are characterized by immune inflammation affecting blood vessels, which can lead to organ and tissue damage.
One study showed that 8% of Wegener's granulomatosis (WG) patients had some degree of AATD (Alpha-1 antitrypsin deficiency). It's perhaps wise for all WG patients to be tested for AATD, especially if they're having bronchiectasis or similar conditions affecting breathing. Some rheumatologists order a lab test for AATD whenever a WG patient is diagnosed.
This presentation, reviews this topic and hypothesize the role of replacement therapy in patients affected by both conditions.
Pharmacodynamics, mechanism of drug actionAsma Aslam
complete information on receptors and their mechanism of actions... briefly discussed about pharmacodynamics and up regulation and desensitization of receptors,
HOW DRUG/MEDICINE WORKORUnderstanding the Mechanisms of Drug ActionTOQIR AHMED
*Introduction*
In the realm of medicine and healthcare, drugs play a vital role in treating various ailments and
improving the quality of life for millions of individuals worldwide. But have you ever wondered how
drugs actually work? In this magazine article, we will delve into the intricate mechanisms behind
pharmaceuticals and explore their fascinating effects on the human body.
*Understanding Drug Action*
At the core, drugs interact with our body’s biological systems to produce specific effects. This interaction
occurs primarily at the molecular level, targeting key proteins and receptors in our cells. By binding to
these targets, drugs can modify the activity of certain enzymes and signaling pathways, leading to a
cascade of physiological changes.
*Modes of Drug Action*
Drugs can exert their effects through a variety of mechanisms. Some drugs work by blocking specific
receptors, preventing other molecules from binding to them. This interference can alter the transmission
of signals and modulate cellular responses.
On the other hand, certain drugs may stimulate receptors, mimicking the action of natural molecules. By
activating these receptors, drugs can trigger a range of responses, from pain relief to immune system
modulation.
*Pharmacokinetics and Pharmacodynamics*
Understanding how drugs are absorbed, distributed, metabolized, and eliminated by the body is crucial
in deciphering their overall effect. Pharmacokinetics refers to how our bodies process drugs, while
pharmacodynamics relates to how drugs interact with specific targets to produce a response.
Factors such as drug solubility, stability, and bioavailability influence the pharmacokinetics of a drug,
determining the dosage and frequency of administration. Pharmacodynamic properties, on the other
hand, define the drug’s effectiveness, potency, and duration of action.
*Drug Classes and Examples*
There exists an extensive array of drug classes, each designed to target particular diseases or symptoms.
From antibiotics that combat bacterial infections to analgesics that alleviate pain, drugs exhibit
astonishing versatility.
For instance, beta-blockers lower blood pressure by blocking receptor sites in the heart, while
anticoagulants prevent blood clotting by inhibiting enzymes involved in the coagulation process. These
examples highlight how drugs can be tailored to tackle specific physiological processes within the body.
*Emerging Approaches in Drug Development*
As medical science advances, novel approaches to drug development are unfolding. Cutting-edge
technologies such as gene therapy, nanomedicine, and personalized medicine are revolutionizing the
field.
Gene therapy aims to correct genetic defects by introducing healthy genes into affected cells.
Nanomedicine employs nanoparticles to deliver drugs directly to targeted tissues, enhancing drug
efficacy while minimizing side effects.
Principles and mechanisms of drug action. Receptor theories and classification of receptors, regulation of receptors. drug
receptors interactions signal transduction mechanisms, G protein–coupled receptors, ion channel receptor, transmembrane enzyme linked receptors,
transmembrane receptor and receptors that regulate
transcription factors, dose response relationship, therapeutic index, combined effects of drugs and factors modifying drug action.
In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect. A mechanism of action usually includes mention of the specific molecular targets to which the drug binds, such as an enzyme or receptor.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Rational use of drugs part i how do drugs work.ppt33
1. HOW DO DRUGS WORK BY INHIBITING ENZYMES?
KEY CONCEPTS:
• Enzymes catalyze the biosynthesis of products from substrates.
• Some drugs bind to enzymes and inhibit enzymatic activity.
• Loss of product due to enzyme inhibition mediates the
effects of enzyme inhibitors.
2. HOW DO DRUGS WORK BY BLOCKING ION CHANNELS?
KEY CONCEPTS:
• Ion channels allow ions to transverse the cell membrane
through a pore and down an electrochemical gradient.
• Some drugs bind to ion channels and physically
block the pore or cause an allosteric change
that closes the pore.
• Changes in the intracellular concentration of ions mediates
the effects of inhibitors of ion channels.
3. ARE DRUGS THAT BLOCK ION CHANNELS
CLINICALLY USEFUL?
Some important examples:
• Calcium Channel Blockers (CCBs) for angina and high blood pressure
(amlodipine [Norvasc®]; diltiazem [Cardizem®])
• Sodium Channel Blockers to suppress cardiac arrhythmias
(lidocaine [Xylocaine®]; amiodarone [Cordarone®])
4. HOW DO DRUGS WORK BY INHIBITING TRANSPORTERS?
Membrane Impermeable Solute
Active Transporter
Membrane Impermeable Solute
Cellular Response
Intracellular
Compartment
5. HOW DO DRUGS WORK BY INHIBITING TRANSPORTERS?
Membrane
Impermeable Solute
Inactive Transporter
Drug that Inhibits Transporters
Membrane
Impermeable Solute
Intracellular
Compartment
6. HOW DO DRUGS WORK BY INHIBITING TRANSPROTERS?
KEY CONCEPTS:
• Transporters bind to and shuttle membrane impermeable
solutes across the cell membrane.
• Some drugs bind to transporters and cause allosteric changes
that prevent proper functioning of the transporters.
• Changes in the intracellular concentration of specific solutes mediates
the effects of inhibitors of transporters.
7. ARE DRUGS THAT INHIBIT TRANSPORTERS
CLINICALLY USEFUL?
Some important examples:
• Selective Serotonin Reuptake Inhibitors (SSRIs) for the
treatment of depression
(fluoxetine [Prozac®]; fluvoxamine [Luvox®])
• Inhibitors of Na-2Cl-K Symporter (Loop Diuretics) in
renal epithelial cells to increase urine and sodium
output for the treatment of edema
(furosemide [Lasix®]; bumetanide [Bumex®])
8. HOW DO DRUGS WORK BY INHIBITING SIGNAL
TRANSDUCTION PROTEINS?
KEY CONCEPTS:
• Signal transduction proteins transmit a chemical signal
from a receptor to the final biological target.
• Some drugs bind to and inhibit key signal transduction proteins.
• Inhibition of key signal transduction proteins may block or
augment the signal transduction pathway and this
mediates the effects of the drug.
9. ARE DRUGS THAT INHIBIT SIGNAL
TRANSDUCTION PROTEINS
CLINICALLY USEFUL?
Some important examples:
• Tyrosine Kinase Inhibitors for chronic myelocytic leukemia
(imatinib [Gleevec®])
• Type 5 Phosphodiesterase Inhibitors for erectile dysfunction
(sildenafil [Viagra®])
• This is a major focus of drug development
10. HOW DO DRUGS WORK BY ACTIVATING
ENDOGENOUS PROTEINS?
• Agonists of Cell Surface Receptors
• Agonists of Nuclear Receptors
• Enzyme Activators
• Ion Channel Openers
11. HOW DO DRUGS WORK BY ACTIVATING
CELL SURFACE RECEPTORS?
Footnote:
Most agonists attach to binding site on receptor for endogenous
agonist and trigger a response.
However, agonists may bind to remote site on receptor and cause
allosteric effects that increase the ability of an endogenous
agonist to bind to or activate the receptor.
12. HOW DO DRUGS WORK BY ACTIVATING CELL
SURFACE RECEPTORS?
KEY CONCEPTS:
• Cell surface receptors exist to transmit chemical signals from
the outside to the inside of the cell.
• Some drugs bind to cell surface receptors and trigger a response.
• Drugs in this group are called receptor agonists.
• Some drug agonists are actually the endogenous chemical signal,
whereas other drug agonists mimic endogenous chemical signals.
13. ARE DRUGS THAT ACTIVATE
CELL SURFACE RECEPTORS
CLINICALLY USEFUL?
Some important examples:
•Alpha1-Adrenoceptor Agonists for nasal congestion
(oxymetazoline [Afrin®]; phenylephrine [Neosynephrine®])
• Opioid Receptor Agonists for analgesia
(morphine; meperidine [Demerol®])
14. HOW DO DRUGS WORK BY ACTIVATING
NUCLEAR RECEPTORS?
Footnote:
Most agonists attach to binding site on receptor for endogenous
agonist and trigger a response.
However, agonists may bind to remote site on receptor and cause
allosteric effects that increase the ability of an endogenous
agonist to bind to or activate the receptor.
15. HOW DO DRUGS WORK BY ACTIVATING
NUCLEAR RECEPTORS?
KEY CONCEPTS:
• Nuclear receptors exist to mediate the effects of intracellular,
endogenous chemicals on gene expression.
• Some drugs bind to nuclear receptors and trigger a response.
• Drugs in this group are called receptor agonists.
• Some drug agonists are actually an endogenous chemical,
whereas other drug agonists mimic an endogenous chemical.
16. ARE DRUGS THAT ACTIVATE
NUCLEAR RECEPTORS
CLINICALLY USEFUL?
Some important examples:
• Estrogen Receptor Agonists for hormone
replacement therapy in postmenopausal
women (conjugated equine estrogens [Premarin®])
• Glucocorticoid Receptor Agonist for inflammation
(hydrocortisone[Cortef®]; dexamethasone [Decadron®])
17. HOW DO DRUGS WORK BY ACTIVATING ENZYMES?
Inactive Enzyme
Substrate
18. HOW DO DRUGS WORK BY ACTIVATING ENZYMES?
Active Enzyme
Substrate
Product
Enzyme Activator
(Drug)
Cellular Function
19. HOW DO DRUGS WORK BY ACTIVATING ENZYMES?
KEY CONCEPTS:
• Enzymes catalyze the biosynthesis of products from substrates.
• Some drugs bind to enzymes and increase their enzymatic activity.
• Increased biosynthesis of product mediates the
effects of enzyme activators.
20. ARE DRUGS THAT ACTIVATE ENZYMES
CLINICALLY USEFUL?
Some important examples:
• Activators of Guanylyl Cyclase for angina
(nitroglycerin; isosorbide dinitrate [Isordil®])
• Reactivators of Cholinesterase after poisoning with nerve gas
or organophosphate pesticide
(pralidoxime [Protopam®])
21. HOW DO DRUGS WORK BY OPENING ION CHANNELS?
Ions (e.g., Ca++, Na+)
Closed Ion Channel
Binding Site on Ion Channel
Ions (e.g., K+)
Intracellular
Compartment
22. HOW DO DRUGS WORK BY OPENING ION CHANNELS?
Ions (e.g., Ca++, Na+, K+)
Open Ion Channel
Drug That Opens Ion Channel
[Ions]
Cellular Response
Intracellular
Compartment
23. HOW DO DRUGS WORK BY OPENING ION CHANNELS?
KEY CONCEPTS:
• Ion channels allow ions to transverse the cell membrane
through a pore and down an electrochemical gradient.
• Some drugs bind to ion channels and allosterically open
the ion channel or allosterically render the
channel more readily opened by
other endogenous chemicals.
• Changes in the intracellular concentration of ions mediates
the effects of drugs that open ion channels.
24. ARE DRUGS THAT OPEN ION CHANNELS
CLINICALLY USEFUL?
Some important examples:
• Potassium Channel Openers for hair regrowth
(minoxidil [Rogaine®])
• GABAAChloride Channel Openers for anxiety
(alprazolam[Xanax®]; midazolam [Versed®])
25. HOW DO DRUGS WORK BY UNCONVENTIONAL
MECHANISMS OF ACTION?
• Disrupters of Structural Proteins
• Drugs that Are Enzymes
• Drugs that Covalently Link to Macromolecules
• Drugs that React Chemically with Small Molecules
• Drugs that Bind Free Molecules or Atoms
26. HOW DO DRUGS WORK BY UNCONVENTIONAL
MECHANISMS OF ACTION (Continued)?
• Drugs that Are Nutrients
• Drugs that Exert Actions Due to Physical Properties
• Drugs that Work Via an Antisense Action
• Drugs that Are Antigens
• Drugs with Unknown Mechanisms of Action
27. DO SOME DRUGS DISRUPT
STRUCTURAL PROTEINS?
Some important examples:
• Vinca Alkaloids for cancer
(vincristine [Oncovin®]; vinblastine [Velban®])
• Colchicine for gout
28. ARE SOME DRUGS ENZYMES?
Some important examples:
• Thrombolytic therapy for acute myocardial infarction
(alteplase [Activase®])
29. DO SOME DRUGS COVALENTLY LINK
TO MACROMOLECULES?
Some important examples:
• DNA alkylating agents for the treatment of cancer
(cyclophosphamide [Cytoxan®]; chlorambucil [Leukeran®])
30. DO SOME DRUGS REACT CHEMICALLY
WITH SMALL MOLECULES?
Some important examples:
• Antacids that neutralize gastric acid
(various preparations containing Al(OH)3, Mg(OH)2 or CaCO3)
31. DO SOME DRUGS BIND FREE
MOLECULES OR ATOMS?
Some important examples:
• Bile-Acid Sequestrants for hypercholesterolemia
(cholestyramine [Questran®])
• Chelating Agents for heavy metal poisoning
(dimercaprol; penicillamine)
• Proteins that bind TNF-α for rheumatoid arthritis
(infliximab [Remicade®]; etanercept [Enbrel®])
32. ARE SOME DRUGS NUTRIENTS?
Some important examples:
• Vitamins, minerals, lipids, carbohydrates, aminoacids
33. DO SOME DRUGS EXERT ACTIONS
DUE TO PHYSICAL PROPERTIES?
Some important examples:
• Bulk Laxatives for constipation
(psyllium [Metamucil®]; polycarbophil [Fibercon®]
• Osmotic Diuretics for edema
(mannitol)
34. DO SOME DRUGS WORK VIA
AN ANTISENSE ACTION?
An important example:
• Antisense Deoxyoligonucleotides for cytomegalovirus retinitis
in patients with AIDS
(fomivirsen [Vitravene®]
• This is a major focus of drug development